Over 60,000 people in Europe had access to cannabis-based drugs for the first time in 2020. Bringing the total number of patients in the region who used cannabis for medical purposes in 2020 to 185,000. Overall, we project that the medicinal cannabis market will be valued €230.7 million by the end of 2020. Additionally. We anticipate that by 2025, the market for cannabis in Europe will be worth €3.2 billion. Growing at a CAGR of 67.4%. Our method for predicting the European cannabis market is based on the Atalis database of historical data points. including sales, patients, volumes, imports, pricing, and other variables.
The chances for firms to establish themselves in specialized areas of the value chain. Before the market becomes more established increase as patient access to medical cannabis expands throughout Europe. The Prohibition Partners Live conferences, the European Cannabis Report: Sixth Edition, and our consulting services for cannabis and psychedelic initiatives are all intended to assist firms in doing this.